Trials / Completed
CompletedNCT06458582
High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 0 Minutes – 2 Minutes
- Healthy volunteers
- Not accepted
Summary
A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High-Flow Nasal Cannula | The intervention involves administering High-Flow Nasal Cannula therapy to very preterm infants immediately after birth. |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2024-06-13
- Last updated
- 2024-11-12
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT06458582. Inclusion in this directory is not an endorsement.